Ana Sayfa
Piyasalar
Grafikler ve Fikirler
Algo
Haberler
Store
Aracı Kurumlar
İndir
Ekonomik Takvim
Alım-Satım Sinyalleri
Web Terminali
Heatmap
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
VSTM
#2881
Verastem, Inc.
6.1
4
USD
+8.48%
Sektör:
Sağlık Hizmetleri
Baz:
USD
Kar Para Birimi:
USD
Günlük Aralık
Yıllık Aralık
Günlük Değişim
+8.48%
Aylık Değişim
+9.45%
6 aylık değişim
-31.40%
Yıllık Değişim
+28.18%
Önceki Kapanış
5.6
6
Open
6.1
4
Bid
Ask
Low
6.1
4
High
6.1
4
Hacim
68
Piyasalar
ABD Borsası
Sağlık Hizmetleri
VSTM
Open full chart
Financials
Overview
Rapor
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
14.31 M
15.53 M
16.72 M
25.3 M
51.49 M
87.84 M
—
Valuation ratios
Enterprise value
301.35 M
363.9 M
35.94 M
173.6 M
219.62 M
549.96 M
1.54 B
Price to earnings ratio
-4.84
-5
-1.1
-2.11
-1.41
-2.56
-7.48
Price to sales ratio
3.69
174.15
0.03
70.51
18.46
17.31
225.66
Price to cash flow ratio
-9.75
-6.68
-0
-2.12
-1.76
-3.89
-11.33
Price to book ratio
2.83
4.08
0
3.19
-6.39
9.35
-18.85
Enterprise value to EBITDA ratio
-31.18
-6.95
-0.13
-1.42
-1.54
-2.87
-7.94
Profitability ratios
Return on assets %
-0.44
-0.66
-0.78
-0.58
-1.29
-0.85
-1.22
Return on equity %
-0.59
-0.81
-1.56
-1.52
4.52
-3.66
6.66
Return on invested capital %
-558.36
-3 623.48
-7 730.47
-5 137.05
-6 190.86
-2 914.79
-3 718.67
Gross margin %
99.1
100
100
0
100
97.74
389.83
Operating margin %
-55.76
-2 991.18
-2 809.59
-3 547.15
-1 149.56
-550.33
-227.45
EBITDA margin %
-10.79
-2 526.64
-2 796.26
—
-1 149.35
-533
—
Net margin %
-76.51
-3 468.1
-2 843.3
-3 365.45
-1 306.37
-677.59
-5 131.02
Liquidity ratios
Quick ratio
—
—
—
—
—
3.07
—
Current ratio
8.48
5.69
4.29
5.45
3.07
3.09
12.63
Inventory turnover
—
—
—
—
—
0.28
—
Asset turnover
0.59
0.02
0.03
0
0.08
0.18
0.16
Solvency ratios
Debt to assets ratio
0.02
0.03
0.28
0.28
0.42
0.31
1.7
Debt to equity ratio
0.03
0.04
0.57
0.72
-1.46
1.34
-3.92
Long term debt to total assets ratio
0
0
0.26
0.27
0.4
0.31
1.68
Long term debt to total equity ratio
0
0
0.52
0.7
-1.41
1.33
-3.86
Per share metrics
Operating cash flow per share
-2.62
-3.68
-3 945.57
-3.92
-2.93
-1.98
-2.08
EBIT per share
-3.86
-4.23
-4 519.63
-4.18
-3.22
-2.45
-2.56
EBITDA per share
-0.75
-3.57
-4 498.19
-4.22
-3.22
-2.38
-2.52
Total debt per share
0.27
0.22
1 660.07
1.88
1.18
1.11
4.57
Cash per share
11.54
6.9
5 446.83
6.22
2.49
2.96
9.23
Net current asset value per share
11.34
7.28
5 754.8
6.52
2.66
3.22
9.98
Tangible book value per share
9.02
6.02
2 936.64
2.6
-0.81
0.59
-0.18
Working capital per share
10.01
6
4 412.43
5.32
1.79
2.18
6.79
Book value per share
9.02
6.02
2 936.64
2.6
-0.81
0.83
0.5
Verastem Inc
Verastem, Inc., doing business as Verastem Oncology, is an American pharmaceutical company that develops medicines to treat certain cancers. Headquartered and founded in Boston, Massachusetts, the firm is a member of NASDAQ Biotechnology Index.
Haberler
The 'Unprecedented' Cancer Test Results That Sent Revolution Medicines Flying
H.C. Wainwright, Verastem hissesi için tavsiyesini korudu
3 Best Stocks to Buy Today, 4/11/2026, According to Top Analysts - TipRanks.com
Verastem hissesi, dayanıklı deneme verileriyle BTIG’de Al tavsiyesi aldı
Verastem’in kanser ilacı kombinasyonu 2 yıllık veride dayanıklılık gösterdi
Cancer Stocks to Buy as Innovation Reshapes Global Oncology Market
Verastem: Maintaining "Buy" As 1st Half 2026 Catalysts In Play (NASDAQ:VSTM)
BTIG, Verastem hissesi için Al önerisiyle kapsama başladı
Verastem stock initiated at Buy by BTIG with $19 price target
Wall Street Analysts See a 159.31% Upside in Verastem (VSTM): Can the Stock Really Move This High?
Jefferies, lansman ilerlemesi sonrası Verastem hisse notunu korudu
Jefferies reiterates Verastem stock rating on launch progress